|
Vonoprazan 20 mg Clinical Trials
1 actively recruiting trial
Also known as: Potassium-competitive acid blocker, TAK-438
Pipeline
Phase 2: 1
Top Sponsors
- King Edward Medical University1
Indications
- Liver Disease1
- Cirrhoses, Liver1
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.